Literature DB >> 10469049

Interferon-gamma (IFN-gamma) and prostaglandin E2 (PGE2) regulate differently IL-12 production in human intestinal lamina propria mononuclear cells (LPMC).

G Monteleone1, T Parrello, I Monteleone, S Tammaro, F Luzza, F Pallone.   

Abstract

IL-12 modulates Th1 immune response during chronic colitis. Mechanisms regulating IL-12 synthesis in human intestine are poorly understood. The aim of this study was to investigate the effect of IFN-gamma and PGE2 on lipopolysaccharide (LPS)-stimulated LPMC IL-12 production. Normal LPMC cultures were run in the presence or absence of IFN-gamma and/or PGE2 before LPS stimulation. To examine the role of endogenous PGE2 on LPS-stimulated IL-12 release, LPMC cultures were added of indomethacin before LPS stimulation. IL-12, IL-10 and IL-8 were measured by ELISA. No IL-12 was detected in either unstimulated or LPS-stimulated LPMC cultures. In contrast, LPMC released IL-8 (650 +/- 125 pg/ml) and IL-10 (75 +/- 25 pg/ml) in response to LPS. Treatment of LPMC with IFN-gamma facilitated LPS-stimulated IL-12, whereas it completely abrogated IL-10 production. IL-12 release by LPMC stimulated with IFN-gamma and LPS was significantly inhibited by exogenous IL-10. The addition of PGE2 to IFN-gamma-treated LPMC cultures inhibited in a dose-dependent manner LPS-induced IL-12 secretion. Furthermore, IL-12 was detectable (85 +/- 25 pg/ml) in the supernatants of LPMC cultures treated with indomethacin and LPS. In contrast to the effect on IL-12, PGE2 significantly augmented LPS-stimulated LPMC IL-10 production. However, the inhibition of IL-12 by PGE2 was only partially reversed by anti-IL-10. In a simplified model of LPS tolerance, we finally showed that monocyte-derived macrophages exhibited reduced IL-12 production after repeat LPS stimulation. In these cell cultures, indomethacin abrogated the induction of LPS desensitization. IFN-gamma and PGE2 modulate differently the LPMC responsiveness to LPS in terms of IL-12 synthesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469049      PMCID: PMC1905357          DOI: 10.1046/j.1365-2249.1999.00991.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  Prostaglandins as potentiators of increased vascular permeability in inflammation.

Authors:  T J Williams; J Morley
Journal:  Nature       Date:  1973-11-23       Impact factor: 49.962

2.  Ulcerative enterocolitis in dogs induced by drugs.

Authors:  T H Stewart; C Hetenyi; H Rowsell; M Orizaga
Journal:  J Pathol       Date:  1980-08       Impact factor: 7.996

3.  IFN-gamma modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding.

Authors:  R B Adams; S M Planchon; J K Roche
Journal:  J Immunol       Date:  1993-03-15       Impact factor: 5.422

4.  Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines.

Authors:  M Betz; B S Fox
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

Review 5.  A new view of prostaglandin E regulation of the immune response.

Authors:  R P Phipps; S H Stein; R L Roper
Journal:  Immunol Today       Date:  1991-10

6.  Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes.

Authors:  F G Snijdewint; P Kaliński; E A Wierenga; J D Bos; M L Kapsenberg
Journal:  J Immunol       Date:  1993-06-15       Impact factor: 5.422

7.  Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers.

Authors:  S Fais; M R Capobianchi; F Pallone; P Di Marco; M Boirivant; F Dianzani; A Torsoli
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

8.  Preexposure of macrophages to low doses of lipopolysaccharide inhibits the expression of tumor necrosis factor-alpha mRNA but not of IL-1 beta mRNA.

Authors:  N Takasuka; T Tokunaga; K S Akagawa
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

9.  Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers.

Authors:  J L Madara; J Stafford
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

10.  Interference with tolerance induction in vivo by inhibitors of prostaglandin synthesis.

Authors:  W V Scheuer; M V Hobbs; W O Weigle
Journal:  Cell Immunol       Date:  1987-02       Impact factor: 4.868

View more
  7 in total

1.  Regulation of lipopolysaccharide-induced interleukin-12 production by activation of repressor element GA-12 through hyperactivation of the ERK pathway.

Authors:  Shinji Saito; Motohiro Matsuura; Yoshikazu Hirai
Journal:  Clin Vaccine Immunol       Date:  2006-08

2.  Inflammatory regulatory T cells in the microenvironments of ulcerative colitis and colon carcinoma.

Authors:  Ilona Kryczek; Lin Wang; Ke Wu; Wei Li; Ende Zhao; Tracy Cui; Shuang Wei; Yan Liu; Yin Wang; Linda Vatan; Wojciech Szeliga; Joel K Greenson; Jacek Roliński; Witold Zgodzinski; Emina Huang; Kaixiong Tao; Guobin Wang; Weiping Zou
Journal:  Oncoimmunology       Date:  2016-08-12       Impact factor: 8.110

3.  Evaluation of an ImmunoPET Tracer for IL-12 in a Preclinical Model of Inflammatory Immune Responses.

Authors:  Nerissa T Viola; James E Glassbrook; Jhansi R Kalluri; Justin B Hackett; Madison N Wicker; Joshua Sternberg; Heather M Gibson
Journal:  Front Immunol       Date:  2022-05-11       Impact factor: 8.786

Review 4.  Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas.

Authors:  Maki Mitsuhashi; Jianguo Liu; Shanjin Cao; Xiaoyan Shi; Xiaojing Ma
Journal:  J Leukoc Biol       Date:  2004-05-03       Impact factor: 4.962

Review 5.  New and Evolving Immunotherapy in Inflammatory Bowel Disease.

Authors:  Mohamad A Raad; Nour H Chams; Ala I Sharara
Journal:  Inflamm Intest Dis       Date:  2016-04-30

6.  Novel anti-inflammatory functions for endothelial and myeloid cyclooxygenase-2 in a new mouse model of Crohn's disease.

Authors:  Junji Watanabe; James A Lin; Ajay J Narasimha; Ani Shahbazian; Tomo-O Ishikawa; Martin G Martin; Harvey R Herschman; Srinivasa T Reddy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-18       Impact factor: 4.052

7.  Leishmania mexicana promastigotes inhibit macrophage IL-12 production via TLR-4 dependent COX-2, iNOS and arginase-1 expression.

Authors:  Muhannad Shweash; H Adrienne McGachy; Juliane Schroeder; Thikryat Neamatallah; Clare E Bryant; Owain Millington; Jeremy C Mottram; James Alexander; Robin Plevin
Journal:  Mol Immunol       Date:  2011-06-12       Impact factor: 4.407

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.